NEULAND LABORATORIES
Back to Income Statement
|
NEULAND LABORATORIES Last 5 Year Profit Before Tax History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹489 Cr | ₹346 Cr | ₹401 Cr | ₹216 Cr | ₹82 Cr |
What is the latest Profit Before Tax of NEULAND LABORATORIES ?
| Year | Profit Before Tax |
|---|---|
| Mar2026 | ₹489 Cr |
| Mar2025 | ₹346 Cr |
| Mar2024 | ₹401 Cr |
| Mar2023 | ₹216 Cr |
| Mar2022 | ₹82 Cr |
How is Profit Before Tax of NEULAND LABORATORIES Trending?
| Years | Profit Before Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹489 Cr | 41.19 | |
| Mar2025 | ₹346 Cr | -13.73 | |
| Mar2024 | ₹401 Cr | 86.07 | |
| Mar2023 | ₹216 Cr | 162.58 | |
| Mar2022 | ₹82 Cr | - | |
Compare Profit Before Tax of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹25,057.4 Cr | 1.5% | -8.5% | 24.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,202.0 Cr | 0.5% | -2.9% | 5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹264,141.0 Cr | 5% | 7.2% | 49.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹174,402.0 Cr | -0.5% | -4.5% | 28.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,868.0 Cr | 2.7% | 8.4% | 5.1% | Stock Analytics | |
| CIPLA | ₹111,650.0 Cr | 2.4% | 2.4% | -12.9% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | 1.5% |
-8.5% |
24.8% |
| SENSEX | 2.8% |
4.4% |
-10.1% |
You may also like the below Video Courses